Nasdaq: JAZZ
Jazz Pharmaceuticals insiders
The officers, directors and 10% owners of Jazz Pharmaceuticals plc who hold the most stock, valued at the live JAZZ price.
$236.45
JAZZ today −$11.3M (−4.57%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 15
- Their JAZZ stock
- $521M
- Market value
- $15.18B
- Held by ranked insiders
- 3.43%
Insiders by value of JAZZ holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Seamus Mulligan | Director | 1,286,254 | $304M | 2.00% | 674th |
| 2 | Bruce C. Cozadd | Director | 357,567 | $84.5M | 0.56% | 1697th |
| 3 | Renee D. Gala | President & CEO | 140,394 | $33.2M | 0.22% | 3403rd |
| 4 | Robert Iannone | EVP, Global Head of R&D & CMO | 65,686 | $15.5M | 0.10% | 6257th |
| 5 | Philip L. Johnson | EVP & Chief Financial Officer | 56,431 | $13.3M | <0.1% | 7069th |
| 6 | Daniel N. Swisher, Jr | President and COO | 55,014 | $13.0M | <0.1% | 7049th |
| 7 | Neena M. Patil | EVP & Chief Legal Officer | 47,671 | $11.3M | <0.1% | 7715th |
| 8 | Samantha Pearce | EVP, Chief Commercial Officer | 47,131 | $11.1M | <0.1% | 8079th |
| 9 | Kenneth W. O.'Keefe | Director | 30,256 | $7.2M | <0.1% | 11229th |
| 10 | Kim Sablich | EVP, GM of U.S. | 28,478 | $6.7M | <0.1% | 11720th |
| 11 | Mary Elizabeth Henderson | SVP, Technical Operations | 23,815 | $5.6M | <0.1% | 13331st |
| 12 | Finbar Larkin | SVP, Technical Operations | 21,779 | $5.1M | <0.1% | 14173rd |
| 13 | Patrick G. Enright | Director | 21,278 | $5.0M | <0.1% | 13567th |
| 14 | Norbert G. Riedel | Director | 17,553 | $4.2M | <0.1% | 6653rd |
| 15 | Ted W. Love | Director | 2,389 | $565K | <0.1% | 13638th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Jazz Pharmaceuticals; see each profile for the filing.